Letrozole Supplier-Buyer Network — Trade Flow Analysis

Name: Letrozole Supplier-Buyer Trade Network Dataset — 252+ Indian Exporters, 21+ Importers, 117+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Letrozole supplier network, Letrozole buyers, pharmaceutical export India, Letrozole trade data

TransData Nexus

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Who Supplies Letrozole? Top Manufacturers & Buyers 2026 — CIPLA LIMITED Leads | TransData Nexus | TransData Nexus

1CIPLA LIMITED

CIPLA LIMITED is the first-largest Letrozole exporter from India, with a market share of 49.2% and a total export value of $15.8M across 82 shipments. Their average shipment value of $192.4K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. THE GOVERNMENT PHARMACEUTICAL is the dominant customer, accounting for 94.5% of this supplier's tracked business. Top customers include:

• THE GOVERNMENT PHARMACEUTICAL — $14.9M across 78 shipments (94.5% of this supplier's total exports)

• PHARMASCIENCE INC .- — $271.7K across 1 shipments (1.7% of this supplier's total exports)

• APOTEX AUSTRALIA — $234.1K across 1 shipments (1.5% of this supplier's total exports)

• ALLOGA UK LTD — $220.1K across 1 shipments (1.4% of this supplier's total exports)

• ALLOGA UK LIMITED — $139.4K across 1 shipments (0.9% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $192.4K is 1167% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

2INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the second-largest Letrozole exporter from India, with a market share of 9.9% and a total export value of $3.2M across 493 shipments. Their average shipment value of $6.4K is below the market average of $15.2K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES LLC — $881.2K across 137 shipments (27.8% of this supplier's total exports)

• ACCORD UK — $878.6K across 137 shipments (27.7% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES LLC — $642.3K across 100 shipments (20.3% of this supplier's total exports)

• TO THE ORDER — $475.1K across 74 shipments (15.0% of this supplier's total exports)

• ACCORD UK — $290.6K across 45 shipments (9.2% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (493 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Letrozole exporter from India, with a market share of 4.0% and a total export value of $1.3M across 56 shipments. Their average shipment value of $23.0K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $424.1K across 18 shipments (32.9% of this supplier's total exports)

• M/S — $235.8K across 10 shipments (18.3% of this supplier's total exports)

• JDS COLIMITED — $235.2K across 10 shipments (18.3% of this supplier's total exports)

• SUN PHARMA EAST AFRI — $215.3K across 9 shipments (16.7% of this supplier's total exports)

• SUN PHARMA EAST AFRI — $177.4K across 8 shipments (13.8% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $23.0K is 51% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

4EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the fourth-largest Letrozole exporter from India, with a market share of 2.7% and a total export value of $850.6K across 119 shipments. Their average shipment value of $7.1K is below the market average of $15.2K, reflecting a high-volume, competitive pricing strategy.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROBINDO PHARMA USA., INC, — $349.9K across 49 shipments (41.1% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC, — $205.3K across 29 shipments (24.1% of this supplier's total exports)

• EUGIA PHARMA (MALTA) — $113.3K across 16 shipments (13.3% of this supplier's total exports)

• EUGIA PHARMA MALTA L — $93.1K across 13 shipments (10.9% of this supplier's total exports)

• SIRON PHARMA SPA — $89.0K across 12 shipments (10.5% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED operates with high shipment frequency (119 shipments) at a per-shipment value of $7.1K, indicating a broad distribution network with many smaller, regular orders.

5NAPROD LIFE SCIENCES PRIVATE LIMITED

NAPROD LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Letrozole exporter from India, with a market share of 1.2% and a total export value of $387.1K across 12 shipments. Their average shipment value of $32.3K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

NAPROD LIFE SCIENCES PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MULTICARE PHARMACEUTICALS PHILIPPIN — $161.8K across 5 shipments (41.8% of this supplier's total exports)

• MULTICARE PHARMACEUTICALS PHILIPPIN — $143.0K across 4 shipments (36.9% of this supplier's total exports)

• MULTICARE PHARMACEUTICALS PHILIPPIN — $82.2K across 3 shipments (21.2% of this supplier's total exports)

• GENIMVE PHARMA S A D — $205 across 0 shipments (0.1% of this supplier's total exports)

Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $32.3K is 112% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

6ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the fifth-largest Letrozole exporter from India, with a market share of 1.1% and a total export value of $359.4K across 35 shipments. Their average shipment value of $10.3K is below the market average of $15.2K, reflecting a high-volume, competitive pricing strategy.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. HEMAS PHARMACEUTICALS (PVT) LTD is the dominant customer, accounting for 61.7% of this supplier's tracked business. Top customers include:

• HEMAS PHARMACEUTICALS (PVT) LTD — $221.6K across 22 shipments (61.7% of this supplier's total exports)

• HEMAS PHARMACEUTICALS (PVT) LTD — $83.2K across 8 shipments (23.2% of this supplier's total exports)

• LABORATORIOS COMBIX — $23.6K across 2 shipments (6.6% of this supplier's total exports)

• NEW GPC INC — $18.0K across 2 shipments (5.0% of this supplier's total exports)

• DHL GLOBAL FORWARDIN — $13.0K across 1 shipments (3.6% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (35 shipments) at a per-shipment value of $10.3K, indicating a broad distribution network with many smaller, regular orders.

1Thailand

Thailand ranks as the first-largest destination for Letrozole imports from India, with a total trade value of $15.5M across 17 shipments — representing a 48.3% share of all Letrozole exports. The average shipment value of $912.0K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Letrozole importers in Thailand: THE GOVERNMENT PHARMACEUTICAL is the largest buyer, accounting for 96.2% ($14.9M) of this market's total imports.

• THE GOVERNMENT PHARMACEUTICAL — $14.9M (96.2% of Thailand's total)

• PHARMALAND (1982) CO. LTD — $287.5K (1.9% of Thailand's total)

• PHARMALAND 1982 CO LIMITED — $264.7K (1.7% of Thailand's total)

Key Insight: Thailand's per-shipment average of $912.0K (5905% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Letrozole imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Letrozole imports from India, with a total trade value of $3.9M across 90 shipments — representing a 12.1% share of all Letrozole exports. The average shipment value of $43.1K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Letrozole importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 39.0% ($1.5M) of this market's total imports.

• EVERSANA LIFE SCIENCES SERVICES,LLC — $1.5M (39.0% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES LLC — $933.2K (24.1% of United States's total)

• AUROBINDO PHARMA USA., INC, — $418.6K (10.8% of United States's total)

Key Insight: United States's per-shipment average of $43.1K (184% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Letrozole imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Letrozole imports from India, with a total trade value of $2.2M across 49 shipments — representing a 7.0% share of all Letrozole exports. The average shipment value of $45.8K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Letrozole importers in United Kingdom: ACCORD UK is the largest buyer, accounting for 64.4% ($1.4M) of this market's total imports.

• ACCORD UK — $1.4M (64.4% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $45.8K (201% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Letrozole imports from India.

Primary Market

Secondary Market

4Philippines

Philippines ranks as the fourth-largest destination for Letrozole imports from India, with a total trade value of $1.6M across 11 shipments — representing a 5.0% share of all Letrozole exports. The average shipment value of $147.2K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Letrozole importers in Philippines: MULTICARE PHARMACEUTICALS PHILIPPIN is the largest buyer, accounting for 22.0% ($356.3K) of this market's total imports.

• MULTICARE PHARMACEUTICALS PHILIPPIN — $356.3K (22.0% of Philippines's total)

• SUN PHARMA PHILIPPINES INC. — $316.3K (19.5% of Philippines's total)

Key Insight: Philippines's per-shipment average of $147.2K (869% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Letrozole imports from India.

Primary Market

Secondary Market

5Australia

Australia ranks as the fifth-largest destination for Letrozole imports from India, with a total trade value of $875.0K across 18 shipments — representing a 2.7% share of all Letrozole exports. The average shipment value of $48.6K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Letrozole importers in Australia: APOTEX AUSTRALIA is the largest buyer, accounting for 55.1% ($481.7K) of this market's total imports.

• APOTEX AUSTRALIA — $481.7K (55.1% of Australia's total)

Key Insight: Australia's per-shipment average of $48.6K (220% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Letrozole imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Letrozole.
2.Flow Mapping: 252 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,112 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 117 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,112 Verified Shipments

252 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Letrozole

Letrozole

Who Supplies Letrozole? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Letrozole — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Letrozole? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Letrozole Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CIPLA LIMITED

2INTAS PHARMACEUTICALS LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4EUGIA PHARMA SPECIALITIES LIMITED

5NAPROD LIFE SCIENCES PRIVATE LIMITED

6ZYDUS LIFESCIENCES LIMITED

From Indian Factories to Global Pharmacies — How Letrozole Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Letrozole Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Thailand

2United States

3United Kingdom

4Philippines

5Australia

People Also Ask — Letrozole Supplier & Trade Network

Letrozole Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology